Prospective, randomized, open-label, clinical trial comparing the effects of sitagliptin and alogliptin on postprandial glucose/lipids metabolism and endothelial function in diabetic patients

Trial Profile

Prospective, randomized, open-label, clinical trial comparing the effects of sitagliptin and alogliptin on postprandial glucose/lipids metabolism and endothelial function in diabetic patients

Completed
Phase of Trial: Phase II

Latest Information Update: 13 May 2016

At a glance

  • Drugs Alogliptin (Primary) ; Sitagliptin (Primary)
  • Indications Diabetes mellitus
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 10 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 03 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top